Diagnostic and therapeutic challenges of hypercalcemia in a patient with localised breast cancer and primary hyperparathyroidism
Katharina Huss-Mischler, Michael Schwitter, Michael Zöller, Rebecca Locher, Niklaus Kamber
Abstract
Open-access reader
Katharina Huss-Mischler, Michael Schwitter, Michael Zöller, Rebecca Locher, Niklaus Kamber
Abstract
Open-access reader
Introduction Primary hyperparathyroidism (PHPT) and malignancy are responsible for more than 90% of all cases of hypercalcemia [1]. Malignancies can cause hypercalcemia because of bone metastases. However, hypercalcemia can also occur in nonmetastatic solid tumours, for example as a result of production of parathyroid hormone-related peptide. The first diagnostic step when
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Introduction Primary hyperparathyroidism (PHPT) and malignancy are responsible for more than 90% of all cases of hypercalcemia [1]. Malignancies can cause hypercalcemia because of bone metastases. However, hypercalcemia can also occur in nonmetastatic solid tumours, for example as a result of production of parathyroid hormone-related peptide. The first diagnostic step when
Key concepts: Primary hyperparathyroidism, Medicine, Breast cancer, Hyperparathyroidism, Cancer, Oncology, Internal medicine